🚀 Exciting opportunity! We're on the hunt for a passionate and driven PhD Fellow to join our dynamic team 👩🔬
If you're eager to push the boundaries of migraine research, we want to hear from you! 🧐🧠
Find out more and apply here: https://t.co/LFeHRIQ5KB
For første gang har genforskere fundet gener, der er særlige for bestemte typer af migræne.
Genudtrykket i specielt to gener afgør ens risiko for at få migræne med eller uden aura, fortæller forskningsleder Thomas Folkmann Hansen. https://t.co/1AnVoiZtve
#dkforsk#sundpol
Twitter, jeg er på en lille mission i dag: En misforståelse om at regeringen skulle skære i Livslinjen begyndte at sprede sig i går. Vi fik det hurtigt rettet i aviserne, men på sociale medier lever den stadig. Tusind tak @madsvolesen og alle andre for at lytte og reagere 🙏
The new impact factor of Cephalalgia, the official journal of The International Headache Society has just been released. Thanks to all authors and reviewers for your big effort throughout the year! #headache#neurology#neuroscience#research
Well, Primary Exercise Headache occurs particularly in hot weather or at high altitudes - two essentials of Tour De France! To read more. go to the ICHD3 website: https://t.co/97DiONU2WO
#headache#ichd3matters#tdf2022#neurology
Cluster #headache: "Attacks occur in series lasting for weeks or months (so-called cluster periods or bouts) separated by remission periods usually lasting months or years."
Check the #clusterheadache diagnostic criteria based on #ICHD3 in the following.
https://t.co/ZTlWHch2sI
According to IHS Guidelines for clinical trials on episodic #migraine, what is the duration of screening + baseline phase before participants' enrolment?
A - 4 wks
B - 8 wks
C - 12 wks
#sundayquiz#ihsheadache#neurology
A recently published paper in the Cephalalgia journal showed that Galcanezumab was well tolerated and improved cluster headache outcomes.
#clusterheadache#headache#cluster#research#ichd3#ihs
https://t.co/JKsFbHPQcI
#MigraineAwareness2021 aims to educate healthcare providers across the 🌎on the correct diagnosis of migraine, and available treatments. Visit our youtube channel for educational videos at different languages. https://t.co/GC2uGEioeb
#neurology#migraineawareness#mham#mham2021
June is US Headache and Migraine Awareness Month, and the whole international headache community joins efforts to raise awareness for these conditions.
Learn about #migraine, #TTH and #clusterheadache on our YT channel:
https://t.co/1GnNMV1Krj
#MHAM2022#neurology#ihsheadache
Registration is now open for the 7th IHS International Headache Academy (iHEAD) to be held in London, UK, from 6-7 Sept 2022.
Deadline: June 30th
More info: https://t.co/55nfke734j
#headache#iHEAD2022#ihsheadache#neurology
IHS is committed to improving #headache care globally. Check out how we're making a difference in healthcare professionals' and researchers' careers worldwide in this open-access @JCephalalgia paper!
@pul_fra@HenrikSchytz
https://t.co/OHDhQiTsdg
#ihsheadache#neurology
Each year in June, headache communities worldwide raise awareness of Migraine. Migraine is most common in those aged 30 to 39, an age span in which prevalence in males and females reaches 7 and 24 percent. Lipton et al., Neurology. 2007
#migraineawareness2022#mham2022
.@JCephalalgia@ihs_official@HenrikSchytz- #Headache patients have attempted several non-pharmacological treatments, but limited pharmacological treatment prior to their first visit at a tertiary headache center. -https://t.co/enc9iJlU8S
#SundayQuiz
In 6.2.4 Persistent headache attributed to past non-traumatic intracranial haemorrhage, what is the minimum duration period of headache after the haemorrhage has stabilized?
#ichd3matters#sundayquiz#ICH#headache
.@JCephalalgia@ihs_official@arne_may - Prof. Cristina Tassorelli - Good science improves the lives of many people and contributes to creating better nations.-https://t.co/E10qdnJi4p